Twitter round-up: Cardiovascular trends in November 2019

10 December 2019 (Last Updated July 6th, 2020 14:07)

Pharmaceutical Technology lists ten of the most popular tweets in cardiovascular in November 2019, based on data from GlobalData’s Influencer Platform. The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a deep analysis of the influencer’s relevance, network strength, engagement, and leading discussions on new and emerging trends.

Twitter round-up: Cardiovascular trends in November 2019

Pharmaceutical Technology lists ten of the most popular tweets in cardiovascular in November 2019, based on data from GlobalData’s Influencer Platform.

The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a deep analysis of the influencer’s relevance, network strength, engagement, and leading discussions on new and emerging trends.

Top tweets in cardiovascular in November 2019

1. Eric Topol’s tweet on wearable health devices

American cardiologist and digital medicine researcher, Eric Topol, shared an article detailing the growing significance of wearable health devices such as the Apple Watch series in maintaining heart health. Users can record the rhythm and heartbeat through the ECG app, which can help in detecting phenomenon such as atrial fibrillation or irregular heart rhythms.

A fingerprint touch on the ECG app for approximately 30 seconds helps in recording electrocardiograms or the electric pulses of the heart. The application is available on the Apple Watch 4 series and above, across regions and countries.

Username: Eric Topol

Twitter handle: @EricTopol

Retweets: 263

Likes: 498

2. Gregg W Stone’s tweet on improved quality of life and reduced angina for patients with baseline angina

An interventional cardiologist, Gregg W Stone tweeted about the results from the ISCHEMIA trial, including improved quality of life and reduced angina in patients with any baseline angina with invasive surgery. According to the American Heart Association’s Scientific Sessions, stable coronary artery disease (CAD) and medium to severe Ischemia led to improvements in angina as well as the quality of life with an invasive strategy.

On the contrary, patients without angina did not experience an improved quality of life with invasive surgery, when compared to a conservative approach.

Username: Gregg W. Stone MD

Twitter handle: @GreggWStone

Retweets: 84

Likes: 165

3. Eric Topol’s tweet on cancer increasing the risk of deaths from cardiovascular disease

Eric Topol tweeted about cancer patients being at two to six times higher risk of dying from heart disease and stroke. The physician-scientist shared an article in his tweet detailing that nearly half the deaths, in breast, endometrial, prostate, and thyroid cancers are caused due to cardiovascular disease (CVD).

The study was carried out at the Penn State College of Medicine and Penn State Cancer Institute, Pennsylvania, US. Approximately 3.2 million cancer cases between 1973 and 2012 were compared with the general population. The results revealed that patients affected with bladder, womb, larynx, prostate, breast, and bowel cancers were at highest risk of dying from CVD.

Username: Eric Topol

Twitter handle: @EricTopol

Retweets: 99

Likes: 165

4. Dr Rohin Francis’ tweet on how incomplete data can be misleading

A Cambridge-trained cardiologist, Dr Rohin Francis tweeted about how earlier researches concluded, in the absence of right data, that smokers enjoyed better health following a heart attack when compared to non-smokers, although the former suffered more heart attacks.

Many studies suggest the paradoxical benefits of smokers being treated with thrombolytic therapy for a myocardial infarction (MI). Results revealed that smokers had their heart attacks at a younger age and hence have fewer comorbidities or heart disease than non-smokers.

Username: Medlife Crisis (Rohin)

Twitter handle: @MedCrisis

Retweets: 94

Likes: 230

5. Mamas’ tweet on dapagliflozoc in reducing cardiovascular deaths

A consultant interventional cardiologist, Mamas tweeted about the benefits of dapagliflozoc in reducing cardiovascular deaths, hospitalisation, and urgent heart failure visits. The influencer shared an infographic from the American Heart Association (AHA) Scientific Sessions 2019, in the same tweet, to state that dapagliflozoc helped in reducing heart failures and cardiovascular deaths in standard therapy.

Additionally, patients with reduced ejection fraction (HFrEF) conditions showed improved symptoms, with or without Type 2 diabetes.

Username: Mamas Mamas

Twitter handle: @mmamas

Retweets: 71

Likes: 145

6. David L Fischman’s tweet on Impella versus IABP in acute myocardial infarction

David L Fischman, a cardiologist, tweeted that Impella could have worse outcomes in a real-world scenario against the traditional intra-aortic balloon pump (IABP) used in treating acute myocardial infarction. This could further be complicated by a cardiogenic shock or the sudden inability of the heart to pump blood for the body, David added.

New studies and findings from the American Heart Association 2019 Scientific Sessions revealed that Impella could be associated with adverse events such as excessive bleeding, in-hospital deaths, and higher costs.

Username: David L. Fischman

Twitter handle: @fischman_david

Retweets: 59

Likes: 147

7. Dr Deepak’s tweet on icosapent ethyl’s ability in reducing all-cause mortality in US patients

A professor of medicine at the Harvard Medical School, Dr Deepak L Bhatt shared an article highlighting that icosapent ethyl reduces cardiovascular risks, with a 30% reduction in all-cause mortality among US patients.

A total of3,146 patients were randomised under the Reduction of Cardiovascular Events with Icosapent Ethyl – Intervention Trial (REDUCE-IT), which was carried out to ascertain the benefit of icosapent ethyl among patients in the US, compared to those enrolled outside. The results revealed that the US group responded more effectively, reducing risks associated with cardiovascular deaths, strokes, and myocardial infarction.

Username: Dr. Deepak L. Bhatt

Twitter handle: @DLBHATTMD

Retweets: 58

Likes: 160

8. Mamas’ tweet on the best practices to prevent radial occlusion (RAO)

A professor and consultant interventional cardiologist, Mamas shared an article on how to prevent radial occlusion (RAO) after a transradial diagnostic angiography and intervention. One of the biggest complications associated with RAO is that the same radial artery cannot be used for future procedures.

Transradialaccess (TRA) is a common procedure currently and is often associated with less bleeding and vascular problems.The incidence of RAO remains high, therefore. The article stresses on the adoption of simple techniques to reduce RAO.

Username: Mamas Mamas

Twitter handle: @mmamas1973

Retweets: 52

Likes: 120

9. SekKathiresan’s tweet on the effectiveness of low-dose Colchicine in reducing cardiovascular events

A physician-geneticist, SekKathiresan shared an article on the safety and efficacy of low-dose Colchicine for reducing cardiovascular events. The article by the New England Journal of Medicine further stated that a randomised trial was conducted on patients diagnosed with myocardial infarction. The patients were administered with low-dose (0.5mg) Colchicine or placebo daily to detect cardiovascular risks, deaths, strokes, hospitalisation for angina, diarrhoea, and pneumonia.

The results revealed that the Colchicine group reported lower risks associated with ischemic cardiovascular events, compared to the placebo group.

Username: SekKathiresan MD

Twitter handle: @skathire

Retweets: 42

Likes: 113

10. Dr Purvi’s tweet on long-term cardiovascular risks in women

A cardiologist based in California, Dr Purvi Parwani tweeted on the cardiovascular risks associated with hypertension in pregnancy. She shared an article posted by the Journal of the American College of Cardiology (JACC), which stated that a history of hypertensive disorder of pregnancy (HDP) should be helpful in detecting cardiovascular risks in women.

A study carried out on 220,024 women revealed that HDP contributes aggressively to the development of cardiovascular diseases. It also found that cardiovascular risks were enhanced after HDP due to chronic hypertension.

Username: Dr.PurviParwani

Twitter handle: @purviparwani

Retweets: 38

Likes: 79